<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Routine surveillance for dysplastic epithelium in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> has markedly improved prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>Many patients with short segments of Barrett's mucosa near the esophagogastric junction remain undiagnosed and at risk for the development of Barrett's <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> (BA) </plain></SENT>
<SENT sid="2" pm="."><plain>Sucrase isomaltase (SI), an intestinal enzyme, is highly expressed in intestinal-type Barrett's mucosa and frequently expressed in dysplastic Barrett's mucosa and BA </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="27" ids="17992">Sucrose</z:chebi> isomaltase is not expressed in <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal or gastric mucosa </plain></SENT>
<SENT sid="4" pm="."><plain>Alterations in the p53 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene are frequent events in dysplastic Barrett's mucosa and BA and result in nuclear protein accumulation </plain></SENT>
<SENT sid="5" pm="."><plain>The purpose of this study was to determine the presence or absence of these markers of Barrett's mucosa in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the esophagogastric junction or cardia </plain></SENT>
<SENT sid="6" pm="."><plain>METHODS: Expression of SI and p53 were examined in 40 BAs and 25 cardia <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> using immunohistochemical techniques </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: <z:chebi fb="27" ids="17992">Sucrose</z:chebi> isomaltase analysis revealed positive staining in 55% (22/40) of the BAs and 44% (11/25) of the cardia <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Of 14 cardia <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> that were SI negative, 100% (14/14) had no associated Barrett's mucosa </plain></SENT>
<SENT sid="9" pm="."><plain>However, in 21 cardia <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> with no associated Barrett's mucosa, 7/21 (33%) were SI positive </plain></SENT>
<SENT sid="10" pm="."><plain>This suggests that SI-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> may represent BA without the standard definition of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> being met </plain></SENT>
<SENT sid="11" pm="."><plain>P53 was present in 65% of BAs and 64% of cardia <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, demonstrating the importance and similarity of this gene alteration in both <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> types </plain></SENT>
<SENT sid="12" pm="."><plain>Staining was positive for SI or p53 in 77% (50/65) of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumors</z:e> of lower stage expressed SI more often than higher stage <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: These data suggest that a subset of cardia <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> represent BAs </plain></SENT>
<SENT sid="15" pm="."><plain>Surveillance endoscopy incorporating additional esophagogastric junction biopsies and assessment of SI or p53 may improve detection of intestinalized Barrett's mucosa and early dysplastic changes </plain></SENT>
</text></document>